Our structural results also suggest that targeting the RNA structure near the QKI binding site in the SERPINA1 3′ UTR would likely increase translation of the A1AT protein, providing a potentially novel site for RNA therapeutic development that could be particularly advantageous to MS, MZ and ZZ individuals with COPD [49]. Here, SERPINA1 is linked to chronic obstructive pulmonary disease.